Articles Tagged With:
-
Improper Medication Leads to Patient’s Death, $10 Million Verdict
In this case, both parties relied heavily on expert opinions to attempt to prove or disprove the causal link between the course of treatment chosen and the onset of the ischemic colitis that led to the patient’s death.
-
Effect of Sleep on Levodopa-Induced Dyskinesia in Parkinson’s Disease
Parkinson’s disease is associated with sleep disorders commonly. Disrupted sleep patterns appear to make dyskinesias worse in patients treated with levodopa therapy.
-
Emergency Preparedness Pays Off When Water Supply Lost
A Utah health system confirmed the value of emergency preparedness when it was faced with a severe water shortage after a wildfire.
-
Pediatric Safety Still Threatened by Electronic Health Records
Pediatric patients are at risk from electronic health records that do not adequately factor in their needs. Medication dosing is the biggest threat.
-
FTC Investigations Could Bring Unwanted Scrutiny to Hospitals
The Federal Trade Commission is investigating whether hospitals and health systems violated antitrust laws through contracts with payers. Assess your risk before the government investigates.
-
Establish Expectations, Communication With Outside Counsel
A hospital is best served when in-house counsel work closely with outside counsel. In-house counsel can provide background information and assistance, as they are the most knowledgeable about the hospital’s structure, policies and procedures, culture, and personalities.
-
Insulin Therapy for Type 2 Diabetes: Social, Psychological, and Clinical Factors
The choices for insulin therapy are ever increasing with the development of new products that provide greater flexibility, greater range of effectiveness, lower risk of hypoglycemia, and lower pharmacokinetic and pharmacodynamic variability. These allow for individualization of treatment to match a patient’s daily life but typically at greater cost. This article will review the psychological, social, and clinical factors pertaining to the various insulin products, as well as strategies to initiate and intensify insulin therapy, to help clinicians supplement and enhance their clinical practices in diabetes management.
-
Outside Counsel Can Be the Right Choice, but Know When
Outside counsel can be an important resource for hospitals and health systems, but knowing when it is right to bring in someone can be difficult.
-
OHRP Issues Guidance on Public Health Surveillance vs. Research
The Office for Human Research Protections recently published new draft guidance to clarify the difference between human research that might require IRB review and public health surveillance that is not defined as research.
-
IRBs Can Learn to Deal With Medical Innovation Ambiguity
The lines between research and medical innovation can be blurry. When does a new surgical practice cross from case study to a study that must adhere to human research protection regulations?